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ABSTRACT  10 
The aim of this study was to determine the efficacy of tart cherry supplementation on recovery 11 
following strenuous exercise. A systematic review and meta-analysis was conducted using studies 12 
investigating tart cherry supplementation on measures of muscle soreness, muscular strength, 13 
muscular power, creatine kinase (CK), C reactive protein (CRP), Interleukin-6 (IL-6) and tumour 14 
necrosis factor alpha (TNFα).  A literature search ending in July 2020 was conducted in 3 databases 15 
(SPORTDiscus, Web of Science and Pubmed).  Data from 14 studies was extracted and pooled for 16 
analysis. Tart cherry supplementation had a small beneficial effect in reducing muscle soreness (ES 17 
= -0.44,  95% CI [-0.87, -0.02]).  A moderate beneficial effect was observed for recovery of muscular 18 
strength (ES = -0.78, 95% CI [-1.11, -0.46]). A moderate effect was observed for muscular power 19 
(ES = -0.53, 95% CI [-0.77, -0.29]), a further subgroup analysis on this variable indicated a large 20 
effect of tart cherry supplementation on recovery of jump height (ES = -0.82, 95% CI [-1.18, -0.45]) 21 
and a small significant effect of supplementation on sprint time (ES = -0.32, 95% CI [-0.60, -0.04]). 22 
A small effect was observed for both CRP (ES = -0.46, 95% CI [-0.93, -0.00]) and IL-6 (ES = -0.35, 23 
95% CI [-0.68, -0.02].  No significant effects were observed for CK, and TNFα. These results indicate 24 
that the consumption of a tart cherry supplement can aid aspects of recovery from strenuous 25 
exercise.  26 
 27 
Key Words: Muscle damage, prunus cerasus, Montmorency cherry, muscle function, 28 
inflammation, functional foods 29 
  30 
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INTRODUCTION  31 
The use of tart cherry (TC) products to aid recovery from strenuous exercise is becoming increasingly 32 
popular.  Consumption of tart cherries is thought to enhance recovery and attenuate symptoms of 33 
exercise induced muscle damage (EIMD), this is likely due to the potent antioxidant and anti-34 
inflammatory properties of the cherry (Connolly et al., 2006; Bowtell et al., 2010; Bongiovanni et al, 35 
2020). 36 
 37 
Strenuous exercise can cause structural damage to the muscle fibre, leading to an inflammatory 38 
response that is characterised by the infiltration of neutrophils and macrophages to the affected area 39 
(Clarkson and Sayers, 1999).  The activity of these immune cells results in the production of reactive 40 
oxygen and nitrogen species (RONS) which can lead to oxidative stress.  Oxidative stress is 41 
considered an imbalance between the natural antioxidant defence systems of the body and the 42 
production of RONS (Betteridge, 2000), if the defence systems become overwhelmed there may be 43 
an exacerbation in the damage to the muscle fibres (Halliwell & Chirico, 1993; Lowe et al., 1995; 44 
Toumi & Best, 2003; Aoi et al., 2004).  Montmorency tart cherries contain high levels of flavonoids 45 
and anthocyanins, the anti-inflammatory and antioxidant properties of these phytonutrients are 46 
purported to reduce inflammation and RONS production via inhibition of the cyclooxygenase (COX-47 
1 and COX-2) pathways (Marzocchella et al., 2011).  Due to this the consumption of TC products is 48 
thought to attenuate the inflammatory response and accelerate recovery from muscle damage, 49 
however it is important to note that these observations have been in vitro or animal models, this has 50 
been reviewed in detail by Marzochella et al (2011). 51 
 52 
 53 
Research investigating the efficacy of TC products as a recovery strategy has been positive, with a 54 
number of studies supporting its use (Connolly et al., 2006; Howatson et al., 2010; Bowtell et al., 55 
2011; Bell et al., 2014a), and a few studies finding no benefit (Beals et al., 2016; McCormick et al., 56 
2016). However, there is wide variation in the responses of the dependent variables that have been 57 
measured throughout the research.  For example, Connolly et al. (2006) observed reduced delayed 58 
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onset muscle soreness (DOMS) with the consumption of TC juice following an eccentric exercise 59 
protocol involving maximal contractions of the elbow flexors, yet Beals et al. (2017) observed no 60 
difference between groups following maximal eccentric contractions of the quadriceps.   61 
Inconsistencies in findings could be related to differences in exercise modalities, exercise familiarity, 62 
duration and type of supplementation, with some studies supplementing with a juice (Howatson et 63 
al., 2008; Quinlan and Hill 2019) and others supplementing with a powder (Levers et al., 2015) or 64 
tablet (Kastello et al., 2014).   65 
 66 
Exercise modality is likely a factor influencing the effectiveness of TC supplementation, as the 67 
underlying cause of symptoms associated with exercise induced muscle damage will vary depending 68 
on exercise stimulus (Levers et al., 2015; Vitale et al., 2017).  The majority of research on TC 69 
supplementation following endurance activity supports the use of TC products to attenuate 70 
inflammation (Howatson et al., 2010; Bell et al., 2014a; Levers et al., 2016) and oxidative stress 71 
(Howatson et al., 2010; Bell et al., 2014a). However, there are inconsistencies in the response of 72 
some markers across studies, for example, three studies observed a decrease in the inflammatory 73 
marker CRP (Bell et al., 2014a; Bell et al 2014b; Howatson et al., 2008) and two observed no 74 
differences (Bell et al., 2016; Quinlan and Hill., 2019).  This makes it difficult to draw conclusions on 75 
the effectiveness of TC as a strategy to reduce EIMD. 76 
 77 
The efficacy of TC supplementation in improving recovery following exercise inducing only 78 
mechanical stress i.e. resistance exercise, is conflicting with studies supporting the use of TC 79 
supplementation (Connolly et al., 2006; Kastello et al., 2014) and others showing no benefit (Beals 80 
et al., 2016; Lamb et al., 2019). As such, a systematic review and meta-analysis of the research 81 
findings will clarify the efficacy of TC supplementation as a recovery strategy and help to identify the 82 
variables most affected by supplementation. Therefore, the aim of this investigation was to conduct 83 





MATERIALS AND METHODS 87 
Literature Search 88 
A systematic review and meta-analysis was conducted using guidelines outlined in the Preferred 89 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Liberati et al., 90 
2009).  An electronic search of the literature ending in July 2020 was conducted in PubMed, 91 
SPORTDiscuss and Web of Science using combinations of the following search terms; cherry OR 92 
Montmorency cherry OR sour cherry OR Prunus cerasus OR Anthocyanin AND recovery OR athlete 93 
OR inflammation OR oxidative stress OR muscle damage OR muscle soreness OR muscle function 94 
OR jump OR sprint OR strength OR exercise OR interleukin 6 OR C reactive protein OR tumor 95 
necrosis factor alpha OR creatine kinase OR reactive oxygen species OR reactive nitrogen species.  96 
The reference lists of all included studies were also examined to identify any further articles.  A three-97 
stage search strategy was independently undertaken by two members of the review team 98 
(Title/Abstract Screen; Full Text Screen/Full Text Appraisal) and results were filtered using the 99 
population, intervention, comparator, outcomes and study design (PICOS) criteria described in Table 100 
1.  101 
**Insert table 1 here** 102 
 103 
Outcome Variables  104 
The literature was examined for the effects of cherry supplementation on indices of recovery 105 
following exercise that induced muscle damage. The following outcome variables were selected as 106 
they reflect the most commonly assessed indices in the EIMD literature: muscular soreness, 107 
muscular strength, muscular power, creatine kinase (CK), C reactive protein (CRP), interleukin-6 (IL-108 
6) and tumor necrosis factor alpha (TNFα).   109 
 110 
Measurements of muscle soreness were obtained from visual analogue or Likert scales.  111 
Measurements of muscular strength were obtained from measurements of maximum isometric, 112 
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isokinetic or isotonic contraction of the muscle.  Measurements of muscular power included any 113 
activity that measured the power of the muscle; for example the counter movement jump (CMJ) or a 114 
sprint. Measurements of CK, CRP, IL-6 and TNFα were obtained from capillary or venous sampling.  115 
 116 
 117 
Inclusion and Exclusion Criteria 118 
Studies were included if they met the following criteria; (1) participants were randomised into a cherry 119 
supplement or a placebo group; (2) if at least one outcome variable was measured at baseline and 120 
again at 1 and/or 24 and/or 48 and/or 72 h after exercise; (3) the study population could be male or 121 
female, of any fitness level or training background; (4) the supplement could be administered before 122 
or after the exercise session.  Studies were excluded if: (1) the experimental group received multiple 123 
treatments; (2) the control group undertook any practice which could have affected recovery; (3) 124 
there was insufficient data, or studies did not yield change score data; (4) a crossover design was 125 
used but not with a contralateral limb, this is due to the contralateral repeated bout effect (Howatson 126 
and van Someren, 2007).   127 
 128 
Extraction of Data 129 
Mean, SD and sample size data were extracted from all included studies and used to calculate 130 
change from baseline scores. Where SD change scores were not reported, values were calculated 131 
using a correlation coefficient. When it was not possible to calculate change scores for SD imputed 132 
SD was calculated in accordance with current guidelines (Higgins and Green, 2011).  Where 133 
necessary mean and SD data were extracted from figures using software ImageJ (NIH, USA). Risk 134 
of bias (Figure 1a and 1b) was assessed following guidelines outlined by the Cochrane Collaboration 135 
(Higgins and Altman, 2008).  The risk of bias assessment was carried out by two authors (JH and 136 
GH) and any discrepancies were reviewed by a third author (KK). Data were extracted and compared 137 




** Insert Figure 1a and Figure 1b here ** 140 
 141 
Statistical Analysis  142 
Analysis on the overall effect of tart cherry supplementation was carried out using Review Manager 143 
5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2011).  Data were 144 
analysed using a random-effect model.  Standardised mean effect sizes (ES) and 95% confidence 145 
intervals (CI’s) were reported as (ES [LCL, UCL]), with LCL and UCL representing lower and upper 146 
95% confidence limits respectively. Where sufficient datapoints allowed, a subgroup analysis was 147 
conducted. For measurement of muscular power, subgroup analysis was carried out on method of 148 
assessing power. Studies were categorised based upon whether they assessed a measure of jump 149 
height or a sprint. For DOMS, strength, CK and CRP subgroup analysis was conducted on type of 150 
damaging protocol used. Studies were categorised as either mechanical or metabolic.  Where 151 
mechanical included studies utilising repetitive effort maximal contractions or maximal effort sprints 152 
and metabolic included studies requiring prolonged engagement of the aerobic system such as a 153 
marathon run or the Loughborough intermittent shuttle test (LIST).  The classification for each study 154 
(mechanical or metabolic) is indicated in table 2.  The threshold values for effect sizes were set at: 155 
≤0.2 (trivial), >0.2 (small), >0.5 (moderate) and >0.8 (large) (Batterham and Hopkins, 2006). 156 
Heterogeneity was assessed using an I2 statistic indicating the percentage of variability across the 157 
studies that is due to heterogeneity (Higgins and Green et al., 2008). The significance level was set 158 
as P≤0.05. 159 
 160 
RESULTS 161 
Database searches identified a total of 6608 records. The majority of these records were not relevant 162 
to this analysis, with many studies relating to other aspects of health, disease and nutrition and thus 163 
were excluded.  Nineteen studies remained for assessment of eligibility.  Five studies were further 164 
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excluded due to: outcome variables not consistent with the inclusion criteria; variables measured at 165 
time points not consistent with the inclusion criteria; missing data; or if people were exposed to 166 
another treatment in addition to cherry supplementation which may have influenced the results (see 167 
Figure 2).  Following this process 14 studies remained for inclusion in this meta-analysis (see Table 168 
2). 169 
 170 
** Insert Figure 2 here **   171 
** Insert Table 2 here ** 172 
A total number of 303 male and female participants were included in the dataset with a mean and 173 
SD age of 26.8 (5.8) years. The training status of the participants was varied ranging from untrained 174 
to well-trained athletes in a range of sports.  The risk of bias assessment is demonstrated in Figure 175 
1.  Adequate sequence generation and allocation concealment was unclear for the majority of the 176 
included studies, with five of the fourteen studies reporting how participants were allocated to groups 177 
and just one study reporting adequate allocation concealment. Adequate blinding occurred in all 178 
included studies with the use of a placebo treatment, in addition outcome data appeared to be 179 
addressed in all included studies. Selective outcome reporting was rated high for two studies as 180 
outcome data was not fully reported or omitted completely. Six of the included studies were 181 
considered at risk of other bias and so were rated high.  Of these studies four implemented either a 182 
low phenolic diet or a dietary wash out period and three studies used a cross over study design.  183 
 184 
A total of 52 data points were extracted from original research papers and included in the analysis 185 
for DOMS (see Figure 3).  A significant difference between groups in favour of cherry 186 
supplementation was evident (P<0.05, Z = 2.06).  Supplementation with cherry products appears to 187 
have a small beneficial effect in attenuating soreness following strenuous exercise (ES = -0.44, 95% 188 
CI [-0.87, -0.02]).  The I2 statistic indicated high heterogeneity in the results (90%, Chi2 = 530.19) 189 
(Higgins and Green, 2008).  A subgroup analysis of exercise type revealed no meaningful reduction 190 
in heterogeneity, with I2 values of 90% (Chi2 = 255.90) and 89% (Chi2 = 273.89) for the metabolic 191 
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and mechanical groups, respectively.  However, the subgroup analysis revealed that TC 192 
supplementation had a significant effect on attenuation of soreness in the mechanical group (P<0.05) 193 
but not the metabolic group (P>0.05). 194 
 195 
Analysis of 39 data points from 11 studies were included in the analysis for muscle strength (Figure 196 
4). Analysis indicated a significant and moderate effect with the use of TC supplementation on the 197 
recovery of muscle strength (P<0.001, Z = 4.76, ES = -0.78, 95% CI [-1.11, -0.46]). A large amount 198 
of heterogeneity was observed across the studies (I2 = 80%, Chi2 = 186.10) (Higgins and Green, 199 
2008).  Further subgroup analysis indicated heterogeneity was reduced to 59% (Chi2 = 26.65) in the 200 
metabolic exercise group indicating minor heterogeneity in this group, however remained high in the 201 
mechanical exercise group (84%, Chi2 = 186.10).  202 
 203 
** Insert Figure 3 here **  204 
 205 
** Insert Figure 4 here ** 206 
 207 
Twenty three data points were used in the analysis for power. When considering the overall results 208 
for power recovery, TC supplementation had a significant and moderate benefit (P < 0.001, Z = 4.39, 209 
ES = -0.53, 95% CI [-0.77, -0.29]) (Figure 5).  A small amount of heterogeneity was observed across 210 
the studies (I2 = 29% Chi2 = 31.17) (Higgins and Green, 2008).  A subgroup analysis carried out on 211 
the type of measure for power revealed that supplementation with TC has a significant and large 212 
effect on recovery of jump height (P < 0.001, Z = 4.41, ES = -0.82, 95% CI [-1.18, -0.45]), with small 213 
heterogeneity (I2 = 28%, Chi2 = 12.53).  The analysis on sprint data revealed a small significant effect 214 
of TC supplementation (P = 0.02, Z = 2.26, ES = -0.32, 95% CI [-0.60, 0.04]).  Heterogeneity was 215 




** Insert Figure 5 here ** 218 
 219 
Consumption of TC had no significant effect on concentrations of CK between groups (P=0.26, Z 220 
=0.26) (Figure 6).  Analysis was conducted on a sample of 32 datapoints revealing small 221 
heterogeneity (I2 = 17%, Chi2 = 6.87) (Higgins and Green, 2008).  Subgroup analysis showed no 222 
significant benefit of TC supplementation on CK for metabolically induced (P=0.79) or mechanically 223 
induced (P=0.10) muscle damage.  224 
An overall small and significant effect in favour of TC supplementation was observed on 225 
concentrations of CRP, conducted on a sample of 20 data points (P=0.05, Z = 1.96, ES = -0.46, 95% 226 
CI [-0.93, -0.00]) (Figure 7). Considerable heterogeneity was observed across the data points (I2 = 227 
78%, Chi2 = 87.59) (Higgins and Green, 2008).  Further subgroup analysis on exercise reduced the 228 
heterogeneity to nothing in the metabolic group (I2 = 0%, Chi2 = 9.98) and indicated a large positive 229 
effect of consuming TC on concentrations of CRP following metabolically induced muscle damage 230 
(P<0.001, Z = 5.62, ES = -0.84, 95% CI [-1.13, -0.54]). Contrasting this, the subgroup analysis 231 
revealed no significant group differences for CRP following mechanically induced muscle damage 232 
(P = 0.79). 233 
Analysis for IL-6, carried out on 21 data points across 6 studies revealed a small significant benefit 234 
of TC supplementation on concentrations of IL-6 (P<0.05, Z = 2.08, ES = -0.35, 95% CI [-1.68, -235 
0.02]) (Figure 8). Moderate heterogeneity was evident in the data set (I2 = 56%, Chi2 = 40.95), 236 
however no subgroup analysis was carried out as only one study induced muscle damage using a 237 
protocol categorised as mechanical. No significant effects of TC supplementation were observed for 238 
TNFα (P=0.27, Z = 1.09) (Figure 9). The heterogeneity across 19 datapoints was low (I2 = 0%) 239 
(Higgins and Green, 2008).  Subgroup analysis was not conducted as only one study induced muscle 240 
damage using a protocol categorised as mechanical.  241 
 242 




** Insert Figure 7 here **   245 
 246 
** Insert Figure 8 here ** 247 
 248 
** Insert Figure 9 here ** 249 
 250 
DISCUSSION 251 
There is an increasing body of literature investigating the effectiveness of TC supplementation as a 252 
recovery strategy; however, the variation in methodological design, study population and exercise 253 
stimulus have resulted in inconsistent findings throughout the literature, with the exception of CK for 254 
which no between group difference has consistently been observed. To the authors knowledge this 255 
is the first study that has used a meta-analysis approach to evaluate the effectiveness of consuming 256 
TC as a recovery strategy. This analysis suggests that supplementation with TC can attenuate losses 257 
in strength and power, reduce the severity of DOMS and attenuate concentrations of CRP and IL-6. 258 
No significant benefits were observed on concentrations of CK and TNFα following TC 259 
supplementation.  260 
 261 
Both metabolic and mechanical factors contribute to the aetiology of EIMD, the contribution of which 262 
will vary depending on the type of exercise (Howatson and van Someren, 2008).  Exercise modalities 263 
with a large endurance component are predominantly fuelled from aerobic pathways and are 264 
associated with high metabolic costs (Vitale et al., 2017; Bell et al., 2014a).  Conversely, modalities 265 
with large eccentric components are typically fuelled via anaerobic pathways and are associated 266 
with higher mechanical stress (Levers et al., 2015; Bell et al., 2014a). Differences in relative 267 
contribution from the different energy systems is likely to impact the type and magnitude of stress 268 
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caused by the exercise protocol (Bell et al., 2014a).  Research has suggested that cherry 269 
supplementation is suited to facilitating recovery from exercise with a large metabolic component 270 
(Bell et al., 2014a). Due to this a subgroup analysis was carried out on exercise type, mechanical or 271 
metabolic.  272 
 273 
A significant and large effect was observed for muscle strength indicating that TC supplementation 274 
was able to accelerate the recovery of muscle strength.  The subgroup analysis on exercise type 275 
indicated this observation was consistent between the metabolic and mechanical exercise groups.  276 
Overall analysis for muscular power revealed a significant and moderate benefit.  For this variable 277 
sub-group analysis was carried out on method of assessment, jump height or sprint test. Subgroup 278 
analysis revealed a significant and large beneficial effect of TC supplementation on jump height and 279 
a significant but small beneficial effect on sprint speed.  These differences in effect size between 280 
subgroups could be due to the mechanics of the different movements, with the CMJ utilizing the 281 
stretch shortening cycle and containing both an eccentric and concentric phase within the movement.  282 
In addition, previous research has indicated a large learning effect with sprint trials (Bell et al., 283 
2014a).  This study observed an improvement in sprint performance over time throughout the 72h 284 
post trial period, this increase in performance was attributed to a learning effect and could explain a 285 
smaller effect size for this measure.   286 
 287 
Muscle damaging exercise leads to a decrease in the force generating capacity of the affected 288 
muscle, this is attributed to myofibrillar disruption and damage to the muscle fibre architecture 289 
(Clarkson and Hubal., 2002). Previous research has indicated that supplementation with TC can 290 
protect against the declines in muscle function that are observed following strenuous exercise (Bell 291 
et al., 2016).  This has been proposed to occur as a result of a reduced acute inflammatory response 292 
(Bell et al., 2016).  This is supported by attenuated inflammatory markers observed in this meta-293 




Supplementation with TC resulted in an overall significant but small effect on both CRP and IL-6 with 296 
lower concentrations observed following TC consumption.  Interestingly the subgroup analysis 297 
carried out for CRP revealed TC supplementation had no significant effect on exercise protocols 298 
categorised as mechanical and a large and significant effect on exercise categorised as metabolic.  299 
Reduced concentrations of CRP have previously been attributed to a reduction in cell damage that 300 
occurs as a result of oxidative stress (Bell et al., 2014a).  Thus, it might be that TC supplementation 301 
is more beneficial to exercise that is more metabolically challenging. It is also possible that prolonged 302 
endurance exercise such as Marathon running could induce a systemic inflammatory response, 303 
enhancing the ability of the TC supplement to have a greater blunting effect on the secondary muscle 304 
damage response (Bell et al., 2014b). A possible explanation for the reduced inflammatory response 305 
is that anthocyanins contained in the TC are able to inhibit the activity of prostaglandin enzymes, 306 
which has been shown to mediate inflammation (Lanier, 2003). It should also be noted that the 307 
exercise modalities classified as metabolic are not all free of mechanical damage. For example, 308 
Marathon running has huge metabolic consequences but the repetitive eccentric contractions 309 
occurring as part of the gait cycle will also induce mechanical damage.  No benefit of 310 
supplementation with TC was observed for TNFα.  A subgroup analysis was not carried out for TNFα 311 
and IL-6 due to the limited number of studies that measured these variables.  312 
 313 
Data from this study indicate that the consumption of TC can attenuate the severity of DOMS, with 314 
the observation of a small beneficial effect in favour of TC.  The subgroup analysis revealed there 315 
was no significant effect of TC supplementation on soreness following exercise that is metabolic in 316 
nature, however there was a significant and moderate reduction in soreness following exercise that 317 
is mechanical in nature. Soreness following damaging exercise has been attributed to increased 318 
oxidative stress and inflammation (Beals et al., 2017), increased sensitivity of nociceptors and 319 
mechanoreceptors to noxious chemicals, including prostaglandins, released during muscle damage 320 
(Clarkson and Hubal., 2002) and microinjury to surrounding tissues that is exacerbated by immune 321 
mediated inflammation (Sonkodi et al., 2020). It is possible that supplementation with TC can inhibit 322 
the cyclooxygenase pathway, reducing the synthesis of prostaglandins (Marzocchella et al., 2011), 323 
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and dampening the secondary muscle damage response (Levers et al., 2015), this could result in 324 
reduced muscle soreness.  Damage to the connective tissue and structures within the muscle fibres 325 
is likely to be greater following exercise that is mechanical in nature giving rise to a greater 326 
inflammatory response, this may explain why TC supplementation has a greater effect following 327 
exercise of a mechanical nature.  328 
 329 
No significant effect of TC supplementation was observed compared to placebo for creatine kinase.  330 
This is not surprising given that none of the 11 studies included in the analysis observed a significant 331 
difference between groups for CK.  High variability exists in the CK response between individuals 332 
and in response to different types of exercise (Brancaccio et al., 2007). In addition to this training 333 
status of the participants greatly affects the CK response to exercise.  The variability in population, 334 
training status and exercise modalities used within the studies included in this meta-analysis may 335 
explain why no significant effects were observed.  In addition to high inter-individual variability, there 336 
is wide variability in the magnitude of change in CK across studies, for example Levers et al. (2016) 337 
observed peak values of 870 IU/L in the TC group compared to Howatson et al. (2010) who observed 338 
peak values of 2227 IU/L in the TC group.  Due to this CK may not be a good marker for exercise 339 
recovery but is a good indicator of the presence of EIMD.  340 
 341 
Supplementation with TC is thought to attenuate RONS induced membrane damage therefore 342 
limiting muscle damage and facilitating recovery.  The results from this meta-analysis provide some 343 
evidence to suggest that supplementation with TC can enhance certain aspects associated with 344 
exercise recovery. A limitation of the present study is that oxidative stress was not included in the 345 
analysis due to a lack of studies measuring the same markers of oxidative stress, therefore it is 346 
difficult to get a mechanistic understanding of the effects of TC.  In addition, whist we tried to classify 347 
exercise modalities based upon exercise type, mechanical or metabolic, many exercise modalities 348 
often incur both mechanical and metabolic stress.  This is important to note.  Further research should 349 
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investigate exercise modalities that isolate metabolic or mechanical stress to better identify whether 350 
TC supplementation is more effective under specific conditions.    351 
 352 
Finally it is important to note that meta-analyses are limited by the data available and there are 353 
several limitations in the literature; (1) the participants of several studies were of mixed gender, there 354 
is no indication of how the menstrual cycle was controlled for in these studies; (2) the mode of 355 
exercise and muscle groups involved varies greatly between studies, this is likely to induce different 356 
levels of muscle damage via different mechanistic pathways, there was also variation in the training 357 
status of the participants, this will affect the severity of the muscle damage experienced; (3) the type 358 
of TC supplement and supplementation protocol varies between studies, with studies administering 359 
various brands of juice (Howatson et al 2008; Bell et al., 2016; Quinlan and Hill 2019) and some 360 
using a powder that is mixed with water (Levers 2015; Levers 2016; Beals et al., 2017).  In addition 361 
to this several studies implemented dietary restrictions asking participants to follow a low phenolic 362 
diet.  This could lead to an over estimation of the intervention effect and has been acknowledged in 363 
the risk of bias assessment.  Limitations 1-3 could all have had an influence on the variability of the 364 
data and may explain why there was large heterogeneity in some of the variables.   Finally(4) 365 
Independent variables were only included in the meta-analysis if three studies had measured and 366 
reported them.  Whilst some studies have assessed markers of oxidative stress, there is not one 367 
marker that has been assessed by three separate studies.   368 
  369 
Conclusion 370 
The results of this systematic review and meta-analysis indicate the supplementation with TC can 371 
aid the recovery of muscle function and attenuate soreness following strenuous exercise. It is 372 
possible that this occurs via a mediated inflammatory response as indicated by attenuations in the 373 
concentration of CRP and IL-6.  Further research is needed that investigates the effects of TC 374 
supplementation on markers of oxidative stress, whilst taking into consideration the limitations of 375 
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these markers.  Although the physiological mechanisms are yet to be fully understood, this meta-376 
analysis provides support for the use of TC to facilitate recovery following strenuous exercise.   377 
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Table 1: Review Inclusion Criteria  532 
Population:  Healthy males and females with no restriction on age, activity level or 
training status. 
Intervention:  Supplementation with a tart cherry product before, or before and after a 
single bout of exercise.   
Comparator:  The effectiveness of supplementation with a tart cherry product on indices 
of recovery from exercise induced muscle damage in comparison to a 
control or placebo group.  
Outcomes:  Measurements of muscular soreness, muscular strength, muscular power 
and blood biomarkers creatine kinase, C reactive protein, interleukin-6 and 
tumour necrosis factor alpha.  
Study Design:  Randomised controlled trials, non-randomised controlled trials and cross 








Table 2. Summary of literature included in the meta-analysis  538 
Author(s) Participant cohort 
(training status, gender, 
number) 
Exercise intervention Supplement type  Supplementation 
protocol 
Outcome variables and 





n=19 male, n=10 female 
Repetitive maximal effort 
isokinetic  eccentric 
contractions of the 
quadriceps to fatigue 
 
TC -30g TartVitaCherry freeze-dried powder with 
0.5% anthocyanins mixed with unsweetened 
Black-Cherry Kool-Aide.   
PL -Sweetened black cherry mixed with 4 g of 
nutribiotic plain rice protein powder. 
 
Two servings per day for 
12 days. Four days prior, 
the day of and 7 days 
following the exercise 
protocol.  
 
↔ DOMS (24, 48, 96, 168) 
↔ Peak concentric torque (24, 48, 96, 
168) 
Bell et al. 
(2014a) ‡ 
Male trained cyclists  
n=16 
 
High intensity stochastic 
cycling trial lasting 109 
minutes completed on 3 
consecutive days 
 
TC - 30ml Cherry Active mixed with 100ml water.   
PL mixed berry cordial with 100ml water and 
maltodextrin 
Two servings per day for 
7 consecutive days.  Four 
days pre and on each trial 
day. 
↔ CK (0, 24, 48) 
↓ IL-6 (0, 24, 48) 
↓ C-RP (0, 24, 48) 
↔ TNFα (0, 24, 48) 
Bell et al. 
(2014b) ‡ 
 
Male trained cyclists  
n=16 
 
High intensity stochastic 
cycling trial lasting 109 
minutes. 
 
TC - 30ml Cherry Active mixed with 100ml water.   
PL mixed berry cordial with 100ml water and 
maltodextrin 
Two servings per day for 
8 consecutive days.  Four 
days pre, the day of and 3 
days post trial.  
 
↔ DOMS (24, 48, 72) 
↔  6s sprint cycle (24, 48, 72) 
↑  MVIC (24, 48, 72) 
↔ CK (0, 1, 24, 48, 72) 
↓ IL-6 (0, 1, 24, 48, 72) 
↓ C-RP (0, 1, 24, 48, 72) 
↔ TNFα (0, 1, 24, 48, 72) 
 
Bell et al. 
(2016) ‡ 
Male semi-professional 
soccer players n=16 
Adapted Loughborough 
Intermittent Shuttle Test  
TC - 30ml Cherry Active mixed with 100ml water.   Two servings per day for 
7 consecutive days. Four 
↓ DOMS (24, 48, 72) 
↑ MVIC (24, 48, 72) 
24 
 
  PL mixed berry cordial with 100ml water and 
maltodextrin 
 
days pre, the day of and 2 
days post trial.  
 
↑ CMJ (24, 48, 72) 
↓ 20m sprint (24, 48, 72) 
↔ CK (0, 1, 24, 48, 72) 
↓ IL-6 (0, 1, 24, 48, 72) 
↔ C-RP (0, 1, 24, 48, 72) 








Well trained male  
participants from 
intermittent team sports 
n=10 
Ten sets of 10 knee 
extensions at 80% 1RM 
with an elongated 
eccentric phase lasting 3 
seconds.  
 
TC - 30 ml Cherry Active concentrate.  
PL - 30 ml Iso-energetic synthetically derived fruit 
concentrate 
 
Two servings per day for 
10 days. Seven days 
before, the day of and 2 
days after. 
 
↑ MVIC (1, 24, 48) 
↔ CK (1, 24, 48) 






Female dancers from a 
University team n=20 
Repeated sprint protocol 
consisting of 15x30 m 
maximal sprints with a 
rapid 10 m deceleration 
phase, each separated 
by 60 s rest.  
 
TC - 30ml Cherry Active mixed with 100ml water.  
PL - 25ml of a synthetically derived fruit 
conentrate with negligible phytochemical content 
diluted with 100ml of water and fortified with 
maltodexterin and whey protein powder 
 
Two servings per day for 
8 days.  Four days pre, 
the day of and 3 days 
post exercise. 
 
↔ DOMS (0, 24, 48, 72) 
↔ MVC (0, 24, 48, 72) 
↑ CMJ (0, 24, 48, 72) 
↔ 30m sprint (0, 24, 48, 72) 
↔ CK (0, 1, 24, 48, 72) 





Male College students 
n=14 
40 (2 X 20) maximal 
eccentric contractions of 
the elbow flexors 
 
TC - 12oz bottle of Cherrypharm.  
PL - unsweetend black cherry Kool-aid mixed 
with water.  
 
Two servings per day for 
8 days.  Three days prior, 
the day of and 4 days 
post. 
↓ DOMS (24, 48, 72, 96) 
↔ Proximal tenderness (24, 48, 72, 
96) 










Marathon runners n=13 
male, n=7 female 
A marathon run TC - 12oz bottle of Cherrypharm.  
PL - fruit flavoured concentrate mixed with 8 fl oz 
water.  
 
Two servings per day for 
8 days. Five days before, 
the day of and 2 days 
post. 
 
↔ DOMS (1, 24, 48) 
↑ MVIC (1, 24, 48) 
↔ CK (1, 24, 48) 
↓ IL-6 (1, 24, 48) 






n=10 male, n=4 female 
Eccentric contractions of 
the bicep.  Ten 
submaximal contractions 
followed by 5 sets of 10 
maximal contractions 
 
TC - A tablet consisting of Cherry Flex paste.  
PL - tablet consisting of cooking oil and red food 
colouring  
 
One tablet twice a day for 
16 days prior to and for 3 
days following exercise 
 
↓ DOMS (12, 24, 48, 72) 
↔ Peak torque (12, 24, 48, 72)  
↔ CK (12, 24, 48, 72)  





Marathon runners n=36 
male, n=18 female 
Hood to Coast relay. 
Average total running 
distance of 26.3±2.5km 
 
TC - 10.5oz bottle of Cherrish.  
PL - unsweetened fruit punch  mixed with water 
 
Two servings per day. 
Seven days prior to and 
the day of the race. 
 









Five sets of 10 unilateral 
eccentric elbow flexions  
TC – 30 ml of Cherry Active diluted with 220ml 
water 
PL – 250ml of blackcurrant flavoured 
maltodextrin sports drink 
Two servings per day.. 
Four days prior to the day 
of and 4 days post 
exercise.  
 
↔ DOMS (1, 24, 48, 72, 96) 
↔ MVIC (1, 24, 48, 72, 96) 





Resistance trained males 
n=23 
 
Ten sets of 10 repetitions 
of a bar bell back squat 
at 70% 1RM with 3 min 
recovery between sets 
TC - 480 mg Powdered tart cherry.  
PL - 480 mg rice flour mixed with water 
 
One serving per day for 
10 days.  Seven days 
before, the day of and 2 
days post exercise. 
↓ DOMS (1, 24, 48) 
↔ MVIC (1, 24, 48) 
↔ CK (1, 24, 48) 
↔ IL-6 (1, 24, 48) 
26 
 





Triathletes n=18 male 
 
21.1km run under 
simulated race 
conditions 
TC - 480 mg Powdered tart cherry.  
PL - 480 mg rice flour mixed with water 
 
One serving per day for 
10 days.  Seven days 
before, the day of and 2 
days post exercise. 
 
↓ DOMS (1, 24, 48) 
↔ CK (1, 24, 48) 
↓ IL-6 (1, 24, 48) 






Team sport players n=8 
male, n=12 female  
Adapted LIST test TC – 30ml of Montmorency tart cherry 
concentrate Holland and Barrett own brand 
mixed with 70ml water 
PL – 25ml of Robinsons summer fruit squash 
mixed with water 
Two servings per day.  
Five days before the day 
of and 2 days post 
exercise.  
↔ DOMS (1, 24, 48) 
↑ MVIC (1, 24, 48) 
↑ CMJ (1, 24, 48) 
↓ 20m sprint (1, 24, 48) 
↔ CK (1, 24, 48) 
↔ C-RP (1, 24, 48) 
CMJ, counter-movement jump; CK, creatine kinase; DOMS, delayed-onset muscle soreness; IL-6, interleukin-6; MVIC, maximum voluntary isometric contraction; PPT, pressure pain threshold; TNFα, tumor 539 
necrosis factor alpha.   540 
Increases or decreases represent improved performance or attenuations in a variable.   541 
TC = tart cherry juice, PL = placebo  542 




FIGURE CAPTIONS  545 
 546 
 547 
Figure 1a. Risk of bias percentile chart, in accordance with the Cochrane Collaboration (Higgins 548 















Figure 3. Forest plot demonstrating a comparison between the consumption of a tart cherry 558 
supplement or a placebo for measures of delayed-onset muscle soreness.  The time point of 559 
measurement post exercise is displayed in brackets on the first column.  a, b and c displayed in 560 





Figure 4. Forest plot demonstrating a comparison between the consumption of a tart cherry 564 
supplement or a placebo for measures of strength.  The time point of assessment post exercise is 565 






Figure 5. Forest plot demonstrating a comparison between the consumption of a tart cherry 570 
supplement or a placebo for measures of power.  The time point of assessment post exercise is 571 






Figure 6. Forest plot demonstrating a comparison between the consumption of a tart cherry 576 
supplement or a placebo for creatine kinase.  The time point of assessment post exercise is 577 






Figure 7. Forest plot demonstrating a comparison between the consumption of a tart cherry 582 
supplement or a placebo for C reactive protein.  The time point of assessment post exercise is 583 










Figure 8. Forest plot demonstrating a comparison between the consumption of a tart cherry 592 
supplement or a placebo for IL-6.  The time point of assessment post exercise is displayed in 593 




Figure 9. Forest plot demonstrating a comparison between the consumption of a tart cherry 598 
supplement or a placebo for TNFα.  The time point of assessment post exercise is displayed in 599 
brackets on the first column.   600 
